Wallerian Degeneration: A Major Component of Early Axonal Pathology in Multiple Sclerosis
- 2 August 2010
- journal article
- research article
- Published by Wiley in Brain Pathology
- Vol. 20 (5), 976-985
- https://doi.org/10.1111/j.1750-3639.2010.00401.x
Abstract
Axonal loss is a major component of the pathology of multiple sclerosis (MS) and the morphological basis of permanent clinical disability. It occurs in demyelinating plaques but also in the so-called normal-appearing white matter (NAWM). However, the contribution of Wallerian degeneration to axonal pathology is not known. Here, we analyzed the extent of Wallerian degeneration and axonal pathology in periplaque white matter (PPWM) and lesions in early multiple sclerosis biopsy tissue from 63 MS patients. Wallerian degeneration was visualized using an antibody against the neuropeptide Y receptor Y1 (NPY-Y1R). The number of SMI-32-positive axons with non-phosphorylated neurofilaments was significantly higher in both PPWM and plaques compared to control white matter. APP-positive, acutely damaged axons were found in significantly higher numbers in plaques compared to PPWM. Strikingly, the number of NPY-Y1R-positive axons undergoing Wallerian degeneration was significantly higher in PPWM and plaques than in control WM. NPY-Y1R-positive axons in PPWM were strongly correlated to those in the lesions. Our results show that Wallerian degeneration is a major component of axonal pathology in the periplaque white matter in early MS. It may contribute to radiological changes observed in early MS and most likely plays a major role in the development of disability.Keywords
This publication has 34 references indexed in Scilit:
- Neurofascin as a novel target for autoantibody-mediated axonal injuryThe Journal of Experimental Medicine, 2007
- Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosisBrain, 2006
- Axonal protection in multiple sclerosis--a particular need during remyelination?Brain, 2006
- The contribution of demyelination to axonal loss in multiple sclerosisBrain, 2006
- Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matterNeuroImage, 2006
- Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?Brain, 2002
- Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosisAnnals of Neurology, 2000
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Axonal damage in acute multiple sclerosis lesionsBrain, 1997
- Monocyte/macrophage differentiation in early multiple sclerosis lesionsAnnals of Neurology, 1995